Trine Saugstrup

Novo Nordisk (Denmark) — Denmark

Medicine · Health Sciences

7h-index798citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(6), Diabetes Treatment and Management(4), Platelet Disorders and Treatments(4), Statistical Methods in Clinical Trials(3), Hemostasis and retained surgical items(3)

Publications12 total

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
The Lancet·2019· 552 cited
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
Diabetes Obesity and Metabolism·2019· 64 citedOpen Access
55-OR: Oral Semaglutide vs. Liraglutide and Placebo in T2D: PIONEER 4
Diabetes·2019
Author response for "Incorporating and Interpreting Regulatory Guidance on Estimands in Diabetes Clinical Trials: The PIONEER 1 Randomized Clinical Trial as an Example"
2019
Author response for "Incorporating and Interpreting Regulatory Guidance on Estimands in Diabetes Clinical Trials: The PIONEER 1 Randomized Clinical Trial as an Example"
2019
Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight<sup>®</sup>) in previously treated patients with severe haemophilia A: interim results of the guardian<sup>™</sup>2 extension trial
Haemophilia·2015· 9 citedOpen Access
The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A
Journal of Thrombosis and Haemostasis·2014· 29 cited
Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m2) – a Post-Hoc Sub-Analysis of the guardian™ Trials
Blood·2014· 5 cited
Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials
Haemophilia·2014· 50 citedOpen Access
Safe Application of a Restrictive Transfusion Protocol in Moderate-Risk Patients Undergoing Cardiac Operations
The Annals of Thoracic Surgery·2014· 22 citedOpen Access
The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots
Blood·2013· 1 cited
International comparative field study of N8 evaluating factor VIII assay performance
Haemophilia·2011· 66 citedOpen Access

Frequent Co-authors

Vanita R. Aroda(3), John B. Buse(3), Morten Donsmark(3), Jeppe Zacho(3), Melanie J. Davies(3), Elena Santagostino(3), Steven R. Lentz(3), Irina Matytsina(3), Richard E. Pratley(2), Aslam Amod(2), Søren T. Hoff(2), Takashi Kadowaki(2), Ildiko Lingvay(2), Michael A. Nauck(2), Karen Boje Pedersen(2), Juris J. Meier(2), Mudi Misgav(2), Víctor Jiménez‐Yuste(2), Sandra Lejniece(2), Robert Klamroth(2)